A global meta-analysis finds that anemia affects 37% of patients with inflammatory bowel disease, highlighting gaps in ...

U.S. Erythropoietin Drugs Market size was USD 4.02 Billion in 2025 and is expected to reach USD 6.18 Billion by 2035 owing to the strong dialysis infrastructure and increasing anemia treatment demand.

Hypomethylating agents are standard in MDS treatment, with new drugs like Rytelo enhancing anemia management. Targeted therapies for IDH1/IDH2 mutations offer promising options, though challenges in ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...

Treating anemia in patients with CKD earlier, before hemoglobin levels fall below 9.0 g/dL, may reduce risks for cardiovascular events. Delaying renal anemia treatment with long-acting ...

The development of new or worsening anemia did not decrease Jakafi’s efficacy in treating primary or secondary myelofibrosis. Patients with primary or secondary myelofibrosis who developed new or ...

During the median follow-up of 2.5 years, 2887 and 429 composite anemia outcomes were recorded in patients receiving SGLT2 inhibitors and GLP-1 RAs, respectively. The incidence rate of composite ...

Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...

Anemia often goes hand-in-hand with multiple myeloma. Sometimes, the cancer causes the anemia. And sometimes, the cancer treatment does. But it's possible to resolve it and feel better. (Photo Credit: ...

Dr Sandip Shah said aplastic anemia can affect anyone, but is more common in younger adults. Symptoms include fatigue, shortness of breath and bleeding.

In normochromic anemia, which is a type of blood disorder, red blood cells have typical concentrations of hemoglobin and are typical in color. It may result from underlying conditions, and treatment ...